Form 4: Agenus Inc. Director Receives Stock Options

Director Thomas L. Harrison was granted 122,500 stock options by Agenus Inc. on April 24, 2026, as part of the company's equity incentive plan.

Summary

• Thomas L. Harrison, a Director at Agenus Inc., was granted 122,500 stock options on April 24, 2026.
• These options were awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.
• The options vest on the one-year anniversary of the grant date, meaning they will be fully vested on April 24, 2027.
• The exercise price for these options is $3.90 per share.
• Following the transaction, Mr. Harrison beneficially owns 122,500 shares of common stock underlying these options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation grant to a director rather than a significant financial event or strategic shift.

Positives

• Director compensation through stock options aligns management incentives with shareholder value.
• The grant of options suggests confidence in the company's future performance and stock appreciation potential.
• The equity incentive plan is designed to attract and retain key personnel.

Negatives

• The value of the options is contingent on the future stock price of Agenus Inc.
• If the stock price does not exceed the exercise price of $3.90, the options may not be exercised profitably.

Risks

• The primary risk is that the company's stock price may not appreciate sufficiently to make the stock options valuable.
• Market volatility and industry-specific challenges could negatively impact Agenus Inc.'s stock performance.

Future Outlook

The future outlook for the stock options is dependent on Agenus Inc.'s stock performance, with full vesting expected one year from the grant date.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aiming to align executive interests with long-term shareholder value creation. This grant to a director at Agenus Inc. is consistent with industry norms for incentivizing leadership.

Stakeholder Impact

• Shareholders: The grant of options does not immediately dilute share count but represents potential future dilution if exercised. It aligns director incentives with stock performance.
• Employees: The equity incentive plan may extend to other employees, fostering a culture of ownership and performance.
• Management: The director receives potential future financial benefit tied to the company's success.

Next Steps

• The stock options will vest on April 24, 2027.
• The director may exercise the options at $3.90 per share after vesting, subject to market conditions and company performance.

Key Dates

Keywords

Agenus Inc., Form 4, Stock Options, Director, Equity Incentive Plan, SEC Filing, Insider Trading, Grant Date, Vesting Schedule